Market Access/ News/ News PTC gets green light for gene therapy Upstaza in EU Phil Taylor AADC deficiency, CHMP, EU, gene therapy, PTC Therapeutics, rare disease, Upstaza 0 Comment PTC Therapeutic’s Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in Share X PTC gets green light for gene therapy Upstaza in EU https://pharmaphorum.com/news/ptc-gets-green-light-for-gene-therapy-upstaza-in-eu/